Search Results - "ILKER YILMAZ, Mahmut"
-
1
Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial
Published in American journal of kidney diseases (01-02-2012)“…Background Fibroblast growth factor 23 (FGF-23) is a marker of endothelial dysfunction and atherosclerotic complications in patients with chronic kidney…”
Get full text
Journal Article -
2
Renal anemia of inflammation: the name is self-explanatory
Published in Blood purification (01-01-2011)“…Anemia is inevitable as chronic kidney disease (CKD) advances. With the advent of erythropoietin-stimulating agents (ESAs), considerable improvement has been…”
Get more information
Journal Article -
3
Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement
Published in ENDOCRINE JOURNAL (2015)“…Patients with hypogonadism have poor cardiovascular and metabolic outcomes, and the effect of testosterone replacement therapy (TRT) is not clear. We…”
Get full text
Journal Article -
4
Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
Published in The journal of clinical endocrinology and metabolism (01-10-2014)“…Background: The chronic kidney disease (CKD)-mineral and bone disorder (MBD) syndrome is an important contributor to the CKD-associated cardiovascular disease…”
Get full text
Journal Article -
5
IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival
Published in PloS one (14-06-2017)“…Increased inflammation, associated with the increase in chronic kidney disease (CKD) stage, has a very important influence in vascular injury and…”
Get full text
Journal Article -
6
Prostate cancer and adiponectin
Published in Urology (Ridgewood, N.J.) (01-06-2005)“…To search for any relation between plasma adiponectin levels and the cellular differentiation or progression of prostate cancer (PCa). PCa is becoming an…”
Get full text
Journal Article -
7
The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine
Published in American journal of kidney diseases (2006)“…Background: Oxidative stress is related to endothelial dysfunction (ED) and cardiovascular outcomes in patients with chronic kidney disease. Increased…”
Get full text
Journal Article -
8
Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients
Published in American journal of nephrology (01-01-2012)“…Magnesium is an essential ion for all living cells because over 300 enzymes require the presence of magnesium for their catalytic action. To date, no group has…”
Get more information
Journal Article -
9
Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD
Published in Clinical journal of the American Society of Nephrology (01-02-2012)“…Both prolactin clearance and production are altered in CKD. In nonrenal populations, emerging evidence suggests that prolactin participates in the…”
Get full text
Journal Article -
10
Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes
Published in Nephrology, dialysis, transplantation (01-11-2011)“…Introduction. Systemic inflammation, endothelial dysfunction and arterial thickening contribute to the elevated cardiovascular risk of dialysis patients…”
Get full text
Journal Article -
11
Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney Disease
Published in Clinical journal of the American Society of Nephrology (01-07-2011)“…Deterioration of kidney function impairs testosterone production, with hypogonadism being common in men with chronic kidney disease (CKD). In nonrenal…”
Get full text
Journal Article -
12
Colchicine in Renal Medicine: New Virtues of an Ancient Friend
Published in Blood purification (2017)“…Colchicine is a plant-derived alkaloid that disrupts the cell microtubule system and accumulates in neutrophils, inhibiting neutrophil adhesion and…”
Get more information
Journal Article -
13
Soluble TWEAK and PTX3 in Nondialysis CKD Patients: Impact on Endothelial Dysfunction and Cardiovascular Outcomes
Published in Clinical journal of the American Society of Nephrology (01-04-2011)“…Chronic kidney disease (CKD) conveys high mortality rates. Soluble TNF-like weak inducer of apoptosis (sTWEAK) and long pentraxin 3 (PTX3) are predictors of…”
Get full text
Journal Article -
14
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
Published in Nephrology, dialysis, transplantation (01-02-2012)“…Hypogonadism or testosterone deficiency is a prevalent condition in men with chronic kidney disease (CKD). Testosterone stimulates erythropoiesis via…”
Get full text
Journal Article -
15
Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model
Published in Clinical and experimental nephrology (01-04-2008)“…Background Oxidative stress plays a role in the mechanism of chronic kidney disease (CKD), and antioxidant regimes are regarded as promising treatment…”
Get full text
Journal Article -
16
Serum uric acid independently predicts cardiovascular events in advanced nephropathy
Published in American journal of nephrology (01-01-2012)“…Chronic kidney disease (CKD) is associated with increased risk for cardiovascular (CV) disease and is also associated with elevated uric acid, which is…”
Get more information
Journal Article -
17
Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients
Published in Clinical journal of the American Society of Nephrology (01-01-2008)“…Vascular calcification and endothelial dysfunction contribute to the development of cardiovascular disease in patients with chronic kidney disease (CKD)…”
Get full text
Journal Article -
18
Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
Published in Clinical journal of the American Society of Nephrology (01-11-2009)“…Recently, we showed that soluble TNF-like weak inducer of apoptosis (sTWEAK) plasma levels are diminished in hemodialysis patients and had additive effects…”
Get full text
Journal Article -
19
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
Published in Life (Basel, Switzerland) (15-06-2022)“…We aimed to evaluate the effect of a combination of natural products on parameters related to inflammation, endothelial dysfunction, and oxidative stress in a…”
Get full text
Journal Article -
20
Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease
Published in Clinical and experimental nephrology (01-08-2013)“…Background Increased inflammation is common in patients with chronic kidney disease (CKD) and is associated with increased adverse cardiovascular events (CVE)…”
Get full text
Journal Article